NEUP
Neuphoria Therapeutics Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$3.77
+0.27%Next report
Analyst consensus
- Next report date
- Oct 5, 2026
- EPS estimate
- -$1.58
- Revenue estimate
- —
Latest reported
- Last report date
- Sep 2, 2026
- EPS actual
- -$0.56
- EPS estimate
- -$0.56
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -388.0%
- Revenue beats (12Q)
- 2
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 5, 2026